BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
94:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
present  with anaemia only,  which is usu-:@0.084242:0.096166:0.475169:0.096166:0.475169:0.080410:0.084242:0.080410:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.005330:0.002913:0.015990:0.003848:0.006523:0.011738:0.008255:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.008255:0.012604:0.011738:0.003848:0.010314:0.005330:0.005330:0.002915:0.015990:0.011738:0.003848:0.012450:0.011738:0.008255:0.003848:0.007466:0.008255:0.011699:0.007466:0.011699:0.006388
ally macrocytic,  but  often  normocytic, :@0.084242:0.112371:0.480484:0.112371:0.480484:0.096615:0.084242:0.096615:0.013143:0.003848:0.003848:0.010314:0.013489:0.018049:0.013143:0.012450:0.005711:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330:0.005330:0.008141:0.013123:0.011699:0.006523:0.005330:0.008143:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.008134:0.011738:0.012604:0.006317:0.018049:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330:0.005330
while the presence of neutropaenia and :@0.084242:0.128577:0.480494:0.128577:0.480494:0.112821:0.084242:0.112821:0.015990:0.011738:0.003848:0.003848:0.012508:0.007851:0.006523:0.011738:0.012508:0.007841:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.007837:0.012604:0.006042:0.007839:0.011738:0.012508:0.011699:0.006523:0.005703:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.007851:0.013143:0.011738:0.013181:0.005330
thrombocytopaenia is more variable. :@0.084242:0.144783:0.480467:0.144783:0.480467:0.129027:0.084242:0.129027:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.019858:0.003848:0.007466:0.019858:0.018049:0.012604:0.005707:0.012508:0.019858:0.010660:0.013143:0.005792:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330:0.005330
About 50% of patients will present with a :@0.084242:0.160989:0.480474:0.160989:0.480474:0.145233:0.084242:0.145233:0.014239:0.013123:0.012604:0.011699:0.006523:0.007791:0.010660:0.010660:0.014913:0.007803:0.012604:0.006042:0.007795:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007801:0.015990:0.003848:0.003848:0.003848:0.007812:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007799:0.015990:0.003848:0.006523:0.011738:0.007801:0.013143:0.005330
pancytopaenia (leukopaenia, anaemia :@0.084242:0.177194:0.480463:0.177194:0.480463:0.161438:0.084242:0.161438:0.013123:0.013143:0.011738:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.013835:0.007100:0.003848:0.012508:0.011699:0.009660:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.013835:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
and thrombocytopaenia). An isolated :@0.084242:0.193400:0.480501:0.193400:0.480501:0.177644:0.084242:0.177644:0.012950:0.011545:0.012989:0.019185:0.006331:0.011545:0.005521:0.012411:0.017857:0.012931:0.012411:0.012257:0.010122:0.006331:0.012411:0.012931:0.012950:0.012315:0.011545:0.003656:0.012950:0.006908:0.005138:0.019185:0.014047:0.011545:0.019185:0.003656:0.007274:0.012411:0.003656:0.012950:0.006331:0.012315:0.013183:0.005330
thrombocytopaenia or neutropaenia is :@0.084242:0.209606:0.480519:0.209606:0.480519:0.193850:0.084242:0.193850:0.006331:0.011545:0.005521:0.012411:0.017857:0.012931:0.012411:0.012257:0.010122:0.006331:0.012411:0.012931:0.012950:0.012315:0.011545:0.003656:0.012950:0.016452:0.012411:0.005600:0.016452:0.011545:0.012315:0.011507:0.006331:0.005519:0.012411:0.012931:0.012950:0.012315:0.011545:0.003656:0.012950:0.016452:0.003656:0.007470:0.005330
seen in less than 5% of patients. In some :@0.084242:0.225811:0.480519:0.225811:0.480519:0.210055:0.084242:0.210055:0.007274:0.012315:0.012315:0.011545:0.008967:0.003656:0.011545:0.008967:0.003656:0.012315:0.007274:0.007274:0.008967:0.006331:0.011545:0.012950:0.011545:0.008967:0.010468:0.014720:0.008967:0.012411:0.005850:0.008967:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005138:0.008967:0.004156:0.011545:0.008967:0.007274:0.012411:0.017857:0.012506:0.005330
rarer subsets, patients may present with a :@0.084242:0.242017:0.480517:0.242017:0.480517:0.226261:0.084242:0.226261:0.005600:0.012950:0.005519:0.012315:0.005600:0.007658:0.007274:0.011507:0.012931:0.007274:0.012315:0.006331:0.007274:0.005138:0.007658:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.007658:0.017857:0.012950:0.010122:0.007658:0.012931:0.005521:0.012315:0.007274:0.012315:0.011545:0.006331:0.007658:0.015798:0.003656:0.006331:0.011545:0.007658:0.013144:0.005330
thrombocytosis. Once suspected, it is best :@0.084242:0.258223:0.480517:0.258223:0.480517:0.242467:0.084242:0.242467:0.006331:0.011545:0.005521:0.012411:0.017857:0.012931:0.012411:0.012257:0.010122:0.006331:0.012411:0.007274:0.003656:0.007274:0.005138:0.006908:0.016529:0.011545:0.012257:0.012315:0.006908:0.007274:0.011507:0.007274:0.012931:0.012315:0.012257:0.006331:0.012315:0.012989:0.005138:0.006908:0.003656:0.006331:0.006908:0.003656:0.007274:0.006908:0.012931:0.012315:0.007274:0.006521:0.005330
to involve a clinical haematologist or hae-:@0.084242:0.274270:0.475152:0.274270:0.475152:0.258514:0.084242:0.258514:0.006331:0.012411:0.006235:0.003656:0.011545:0.010468:0.012411:0.003656:0.010468:0.012315:0.006235:0.012950:0.006235:0.012257:0.003656:0.003656:0.011545:0.003656:0.012257:0.012950:0.003656:0.006235:0.011545:0.012950:0.012315:0.017857:0.012950:0.006331:0.012411:0.003656:0.012411:0.012758:0.003656:0.007274:0.006331:0.006235:0.012411:0.005600:0.006235:0.011545:0.012950:0.012315:0.006388
matopathologist to assist with further inves-:@0.084242:0.290317:0.475171:0.290317:0.475171:0.274561:0.084242:0.274561:0.017857:0.012950:0.006331:0.012411:0.012931:0.012950:0.006331:0.011545:0.012411:0.003656:0.012411:0.012758:0.003656:0.007274:0.006331:0.005580:0.006331:0.012411:0.005580:0.012950:0.007274:0.007274:0.003656:0.007274:0.006331:0.005580:0.015798:0.003656:0.006331:0.011545:0.005580:0.005850:0.011507:0.005600:0.006331:0.011545:0.012315:0.005600:0.005580:0.003656:0.011545:0.010468:0.012315:0.007274:0.006388
tigations on the bone marrow, as there are :@0.084242:0.306364:0.480549:0.306364:0.480549:0.290608:0.084242:0.290608:0.006331:0.003656:0.012758:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005167:0.012411:0.011545:0.005176:0.006331:0.011545:0.012315:0.005167:0.012931:0.012411:0.011545:0.012315:0.005176:0.017857:0.012950:0.005600:0.005521:0.012411:0.015798:0.005138:0.005176:0.012950:0.007274:0.005176:0.006331:0.011545:0.012315:0.005521:0.012315:0.005176:0.012950:0.005519:0.012506:0.005330
a number of critical cytogenetic tests (e.g., :@0.084242:0.322411:0.480480:0.322411:0.480480:0.306655:0.084242:0.306655:0.012950:0.004695:0.011545:0.011507:0.017857:0.012931:0.012315:0.005600:0.004695:0.012411:0.005850:0.004695:0.012257:0.005600:0.003656:0.006331:0.003656:0.012257:0.012950:0.003656:0.004695:0.012257:0.010122:0.006331:0.012411:0.012758:0.012315:0.011545:0.012315:0.006331:0.003656:0.012257:0.004695:0.006331:0.012315:0.007274:0.006331:0.007274:0.004695:0.006908:0.012315:0.005138:0.012758:0.005138:0.005328:0.005330
karyotyping, fluorescent :@0.084242:0.338458:0.307828:0.338458:0.307828:0.322702:0.084242:0.322702:0.009467:0.012950:0.005600:0.010122:0.012411:0.006331:0.010122:0.012931:0.003656:0.011545:0.012758:0.005138:0.004610:0.004570:0.004570:0.011507:0.012411:0.005519:0.012315:0.007274:0.012257:0.012315:0.011545:0.006331:0.005330
in situ:@0.307089:0.338458:0.355868:0.338458:0.355868:0.322702:0.307089:0.322702:0.003656:0.011545:0.004618:0.007274:0.003656:0.006331:0.011699
 hybridisation :@0.355676:0.338458:0.480478:0.338458:0.480478:0.322702:0.355676:0.322702:0.004618:0.011545:0.010122:0.012931:0.005600:0.003656:0.012989:0.003656:0.007274:0.012950:0.006331:0.003656:0.012411:0.011734:0.005330
(FISH)) and sometimes others that need to :@0.084242:0.354505:0.480495:0.354505:0.480495:0.338749:0.084242:0.338749:0.006908:0.009140:0.004156:0.009390:0.012950:0.006908:0.006908:0.006510:0.012950:0.011545:0.012989:0.006510:0.007274:0.012411:0.017857:0.012315:0.006331:0.003656:0.017857:0.012315:0.007274:0.006510:0.012411:0.006331:0.011545:0.012315:0.005600:0.007274:0.006510:0.006331:0.011545:0.012950:0.006331:0.006510:0.011545:0.012315:0.012315:0.012989:0.006512:0.006331:0.012600:0.005330
be done upfront to avoid having to repeat :@0.084242:0.370552:0.480494:0.370552:0.480494:0.354796:0.084242:0.354796:0.012931:0.012315:0.004984:0.012989:0.012411:0.011545:0.012315:0.004984:0.011507:0.012931:0.005850:0.005521:0.012411:0.011545:0.006331:0.004984:0.006331:0.012411:0.004984:0.012950:0.010468:0.012411:0.003656:0.012989:0.004984:0.011545:0.012950:0.010468:0.003656:0.011545:0.012758:0.004984:0.006331:0.012411:0.004984:0.005519:0.012315:0.012931:0.012315:0.012950:0.006521:0.005330
the bone-marrow test. The results of these :@0.084242:0.386599:0.480532:0.386599:0.480532:0.370843:0.084242:0.370843:0.006331:0.011545:0.012315:0.007312:0.012931:0.012411:0.011545:0.012315:0.006196:0.017857:0.012950:0.005600:0.005521:0.012411:0.015798:0.007312:0.006331:0.012315:0.007274:0.006331:0.005138:0.007312:0.008005:0.011545:0.012315:0.007312:0.005519:0.012315:0.007274:0.011507:0.003656:0.006331:0.007274:0.007312:0.012411:0.005850:0.007312:0.006331:0.011545:0.012315:0.007274:0.012506:0.005330
tests form a critical component of the prog-:@0.084242:0.402646:0.475142:0.402646:0.475142:0.386890:0.084242:0.386890:0.006331:0.012315:0.007274:0.006331:0.007274:0.003964:0.005850:0.012411:0.006131:0.017857:0.003964:0.012950:0.003964:0.012257:0.005600:0.003656:0.006331:0.003656:0.012257:0.012950:0.003656:0.003964:0.012257:0.012411:0.017857:0.012931:0.012411:0.011545:0.012315:0.011545:0.006331:0.003964:0.012411:0.005850:0.003964:0.006331:0.011545:0.012315:0.003964:0.012931:0.005521:0.012411:0.012758:0.006388
nostic scoring systems used to estimate the :@0.084242:0.418693:0.480519:0.418693:0.480519:0.402937:0.084242:0.402937:0.011545:0.012411:0.007274:0.006331:0.003656:0.012257:0.005215:0.007274:0.012257:0.012411:0.005600:0.003656:0.011545:0.012758:0.005215:0.007274:0.010122:0.007274:0.006331:0.012315:0.017857:0.007274:0.005215:0.011507:0.007274:0.012315:0.012989:0.005215:0.006331:0.012411:0.005215:0.012315:0.007274:0.006331:0.003656:0.017857:0.012950:0.006331:0.012315:0.005215:0.006331:0.011545:0.012506:0.005330
level of risk for transformation to AML, a fac-:@0.084242:0.434740:0.475221:0.434740:0.475221:0.418984:0.084242:0.418984:0.003656:0.012315:0.010468:0.012315:0.003656:0.004137:0.012411:0.005850:0.004137:0.005600:0.003656:0.007274:0.009467:0.004137:0.005850:0.012411:0.005600:0.004137:0.006331:0.005600:0.012950:0.011545:0.007274:0.005850:0.012411:0.006131:0.017857:0.012950:0.006331:0.003656:0.012411:0.011545:0.004137:0.006331:0.012411:0.004137:0.014047:0.017491:0.008698:0.005138:0.004137:0.012950:0.004137:0.005850:0.012950:0.012257:0.006388
tor which will have a major impact on the :@0.084242:0.450787:0.480442:0.450787:0.480442:0.435031:0.084242:0.435031:0.006331:0.012411:0.005600:0.006485:0.015798:0.011545:0.003656:0.012257:0.011545:0.006485:0.015798:0.003656:0.003656:0.003656:0.006485:0.011545:0.012950:0.010468:0.012315:0.006485:0.012950:0.006485:0.017857:0.012950:0.003714:0.012411:0.005600:0.006485:0.003656:0.017857:0.012931:0.012950:0.012257:0.006331:0.006485:0.012411:0.011545:0.006485:0.006331:0.011545:0.012506:0.005330
treatment choice for an individual patient. :@0.084242:0.466834:0.480513:0.466834:0.480513:0.451078:0.084242:0.451078:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005638:0.012257:0.011545:0.012411:0.003656:0.012257:0.012315:0.005638:0.005850:0.012411:0.005600:0.005638:0.012950:0.011545:0.005638:0.003656:0.011545:0.012989:0.003656:0.010468:0.003656:0.012989:0.011507:0.012950:0.003656:0.005638:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.005326:0.005330
Investigation  for the more  common  cy-:@0.084242:0.482881:0.475198:0.482881:0.475198:0.467125:0.084242:0.467125:0.004156:0.011545:0.010468:0.012315:0.007274:0.006331:0.003656:0.012758:0.012950:0.006331:0.003656:0.012411:0.011545:0.005330:0.006725:0.005850:0.012411:0.005600:0.012065:0.006331:0.011545:0.012315:0.012065:0.017857:0.012411:0.005521:0.012315:0.005330:0.006725:0.012257:0.012411:0.017857:0.017857:0.012411:0.011545:0.005330:0.006725:0.012257:0.010122:0.006388
togenetic abnormalities with karyotyping :@0.084242:0.498928:0.480492:0.498928:0.480492:0.483172:0.084242:0.483172:0.006331:0.012411:0.012758:0.012315:0.011545:0.012315:0.006331:0.003656:0.012257:0.010641:0.012950:0.012931:0.011545:0.012411:0.006131:0.017857:0.012950:0.003656:0.003656:0.006331:0.003656:0.012315:0.007274:0.010641:0.015798:0.003656:0.006331:0.011545:0.010641:0.009467:0.012950:0.005600:0.010122:0.012411:0.006331:0.010122:0.012931:0.003656:0.011545:0.012948:0.005330
or FISH has become routine for diagnosis :@0.084242:0.514988:0.480503:0.514988:0.480503:0.499232:0.084242:0.499232:0.012411:0.005600:0.008928:0.009140:0.004156:0.009390:0.012950:0.008928:0.011545:0.012950:0.007274:0.008928:0.012931:0.012315:0.012257:0.012411:0.017857:0.012315:0.008928:0.005521:0.012411:0.011507:0.006331:0.003656:0.011545:0.012315:0.008928:0.005850:0.012411:0.005600:0.008928:0.012989:0.003656:0.012950:0.012758:0.011545:0.012411:0.007274:0.003656:0.007470:0.005330
and prognostication, while screening for :@0.084242:0.531035:0.480492:0.531035:0.480492:0.515279:0.084242:0.515279:0.012950:0.011545:0.012989:0.011026:0.012931:0.005521:0.012411:0.012758:0.011545:0.012411:0.007274:0.006331:0.003656:0.012257:0.012950:0.006331:0.003656:0.012411:0.011545:0.005138:0.011026:0.015798:0.011545:0.003656:0.003656:0.012315:0.011026:0.007274:0.012257:0.005521:0.012315:0.012315:0.011545:0.003656:0.011545:0.012758:0.011026:0.005850:0.012411:0.005786:0.005330
the now more than 100 known mutations :@0.084242:0.547082:0.480480:0.547082:0.480480:0.531326:0.084242:0.531326:0.006331:0.011545:0.012315:0.008043:0.011545:0.012411:0.015798:0.008043:0.017857:0.012411:0.005519:0.012315:0.008043:0.006331:0.011545:0.012950:0.011545:0.008043:0.010468:0.010468:0.010468:0.008043:0.009467:0.011545:0.012411:0.015798:0.011545:0.008043:0.017857:0.011507:0.006331:0.012950:0.006331:0.003656:0.012411:0.011545:0.007468:0.005330
with novel molecular methodologies, (e.g., :@0.084242:0.563129:0.480507:0.563129:0.480507:0.547373:0.084242:0.547373:0.015798:0.003656:0.006331:0.011545:0.005086:0.011545:0.012411:0.010468:0.012315:0.003656:0.005088:0.017857:0.012411:0.003656:0.012315:0.012257:0.011507:0.003656:0.012950:0.005600:0.005088:0.017857:0.012315:0.006331:0.011545:0.012411:0.012989:0.012411:0.003656:0.012411:0.012758:0.003656:0.012315:0.007274:0.005138:0.005088:0.006908:0.012315:0.005138:0.012758:0.005138:0.005326:0.005330
next-generation sequencing) is not yet :@0.084242:0.579176:0.480499:0.579176:0.480499:0.563420:0.084242:0.563420:0.011545:0.012315:0.009044:0.006331:0.006196:0.012758:0.012315:0.011545:0.012315:0.005600:0.012950:0.006331:0.003656:0.012411:0.011545:0.014720:0.007274:0.012315:0.012931:0.011507:0.012315:0.011545:0.012257:0.003656:0.011545:0.012758:0.006908:0.014720:0.003656:0.007274:0.014720:0.011545:0.012411:0.006331:0.014720:0.010122:0.012315:0.006521:0.005330
widely available.:@0.084242:0.595223:0.238778:0.595223:0.238778:0.579467:0.084242:0.579467:0.015798:0.003656:0.012989:0.012315:0.003656:0.010122:0.005138:0.012950:0.010468:0.012950:0.003656:0.003656:0.012950:0.012931:0.003656:0.012315:0.005330
PATHOPHYSIOLOGY:@0.084242:0.628051:0.307198:0.628051:0.307198:0.608454:0.084242:0.608454:0.013170:0.017404:0.009878:0.015993:0.019756:0.013170:0.015993:0.014581:0.012230:0.006585:0.019756:0.010348:0.019756:0.019756:0.014581
The pathophysiology of MDS is incom-:@0.084242:0.646397:0.475152:0.646397:0.475152:0.630641:0.084242:0.630641:0.008197:0.011738:0.012508:0.013181:0.013123:0.013143:0.006523:0.011738:0.012604:0.013123:0.011738:0.010314:0.007466:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.013181:0.012604:0.006042:0.013181:0.017684:0.014316:0.009583:0.013181:0.003848:0.007466:0.013181:0.003848:0.011738:0.012450:0.012604:0.018049:0.006388
pletely understood and is made more dif-:@0.084242:0.662444:0.475148:0.662444:0.475148:0.646688:0.084242:0.646688:0.013123:0.003848:0.012508:0.006523:0.012508:0.003848:0.010314:0.006061:0.011699:0.011738:0.013181:0.012508:0.005792:0.007466:0.006523:0.012604:0.012604:0.013181:0.006044:0.013143:0.011738:0.013181:0.006061:0.003848:0.007466:0.006061:0.018049:0.013143:0.013181:0.012508:0.006061:0.018049:0.012604:0.005709:0.012508:0.006061:0.013181:0.003848:0.006042:0.006388
ficult due to the large range of mutations :@0.084242:0.678491:0.480491:0.678491:0.480491:0.662735:0.084242:0.662735:0.004686:0.004686:0.012450:0.011699:0.003848:0.006523:0.006444:0.013181:0.011699:0.012508:0.006448:0.006523:0.012604:0.006442:0.006523:0.011738:0.012508:0.006448:0.003848:0.013143:0.005813:0.012950:0.012508:0.006444:0.005792:0.013143:0.011738:0.012950:0.012508:0.006440:0.012604:0.006042:0.006444:0.018049:0.011699:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
found.  MDS is caused by a stepwise ac-:@0.084242:0.694538:0.475154:0.694538:0.475154:0.678782:0.084242:0.678782:0.006042:0.012604:0.011699:0.011738:0.013181:0.005330:0.005330:0.003081:0.017684:0.014316:0.009583:0.008428:0.003848:0.007466:0.008428:0.012450:0.013143:0.011699:0.007466:0.012508:0.013181:0.008428:0.013123:0.010314:0.008428:0.013143:0.008428:0.007466:0.006523:0.012508:0.013123:0.015990:0.003848:0.007466:0.012508:0.008428:0.013143:0.012450:0.006388
cumulation of mutations in a haematopoi-:@0.084242:0.710585:0.475171:0.710585:0.475171:0.694829:0.084242:0.694829:0.012450:0.011699:0.018049:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.004532:0.012604:0.006042:0.004532:0.018049:0.011699:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.004541:0.003848:0.011738:0.004541:0.013143:0.004541:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.013123:0.012604:0.003848:0.006388
etic progenitor  cell, which leads to  the :@0.084242:0.726632:0.480493:0.726632:0.480493:0.710876:0.084242:0.710876:0.012508:0.006523:0.003848:0.012450:0.010737:0.013123:0.005715:0.012604:0.012950:0.012508:0.011738:0.003848:0.006523:0.012604:0.005792:0.005330:0.005390:0.012450:0.012508:0.003848:0.003848:0.005330:0.010737:0.015990:0.011738:0.003848:0.012450:0.011738:0.010737:0.003848:0.012508:0.013143:0.013181:0.007466:0.010737:0.006523:0.012604:0.005330:0.005397:0.006523:0.011738:0.012508:0.005330
formation of a malignant clone. It is con-:@0.084242:0.742679:0.475159:0.742679:0.475159:0.726923:0.084242:0.726923:0.006042:0.012604:0.006319:0.018049:0.013143:0.006523:0.003848:0.012604:0.011738:0.007062:0.012604:0.006042:0.007062:0.013143:0.007062:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.007062:0.012450:0.003848:0.012604:0.011738:0.012508:0.005330:0.007062:0.004349:0.006523:0.007062:0.003848:0.007466:0.007062:0.012450:0.012604:0.011738:0.006388
sidered  and  classified  as  a  malignancy. :@0.084242:0.758726:0.480478:0.758726:0.480478:0.742970:0.084242:0.742970:0.007466:0.003848:0.013181:0.012508:0.005719:0.012508:0.013181:0.005330:0.004836:0.013143:0.011738:0.013181:0.005330:0.004838:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.004847:0.013143:0.007466:0.005330:0.004841:0.013143:0.005330:0.004838:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.005330:0.005330
These  may occur :@0.084242:0.774773:0.257874:0.774773:0.257874:0.759017:0.084242:0.759017:0.008197:0.011738:0.012508:0.007466:0.012508:0.005330:0.004356:0.018049:0.013143:0.010314:0.009698:0.012604:0.012450:0.012450:0.011699:0.005792:0.005330
de novo:@0.262234:0.774773:0.345227:0.774773:0.345227:0.759017:0.262234:0.759017:0.013181:0.012508:0.009698:0.011738:0.012604:0.010660:0.012604
 with ageing, :@0.345227:0.774773:0.480520:0.774773:0.480520:0.759017:0.345227:0.759017:0.009698:0.015990:0.003848:0.006523:0.011738:0.009698:0.013143:0.012950:0.012508:0.003848:0.011738:0.012950:0.005330:0.005330
or may be secondary to exposure to cer-:@0.084242:0.790833:0.475152:0.790833:0.475152:0.775077:0.084242:0.775077:0.012604:0.005792:0.006562:0.018049:0.013143:0.010314:0.006562:0.013123:0.012508:0.006562:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.006562:0.006523:0.012604:0.006562:0.012508:0.009236:0.013123:0.012604:0.007466:0.011699:0.005715:0.012508:0.006562:0.006523:0.012604:0.006562:0.012450:0.012508:0.005792:0.006388
tain environmental factors (e.g., tobacco, :@0.084242:0.806880:0.480495:0.806880:0.480495:0.791124:0.084242:0.791124:0.006523:0.013143:0.003848:0.011738:0.005070:0.012508:0.011738:0.010660:0.003848:0.005717:0.012604:0.011738:0.018049:0.012498:0.011738:0.006523:0.013143:0.003848:0.005070:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005063:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.005061:0.006523:0.012604:0.013123:0.013143:0.012450:0.012450:0.012604:0.005330:0.005330
benzene, chemotherapy, radiation [acci-:@0.084242:0.822927:0.475155:0.822927:0.475155:0.807171:0.084242:0.807171:0.013123:0.012508:0.011738:0.008178:0.012508:0.011738:0.012508:0.005330:0.006196:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.006200:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006215:0.006754:0.013143:0.012450:0.012450:0.003848:0.006388
dental or therapeutic], and so on). Some :@0.084242:0.838974:0.480511:0.838974:0.480511:0.823218:0.084242:0.823218:0.013181:0.012508:0.011738:0.006523:0.013143:0.003848:0.007004:0.012604:0.005792:0.007004:0.006523:0.011738:0.012508:0.005792:0.013133:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.006754:0.005330:0.007004:0.013143:0.011738:0.013181:0.007004:0.007466:0.012604:0.007004:0.012604:0.011738:0.007100:0.005330:0.007004:0.009583:0.012604:0.018049:0.012508:0.005330
patients have an underlying predisposing :@0.084242:0.855180:0.480489:0.855180:0.480489:0.839424:0.084242:0.839424:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006985:0.011738:0.013143:0.010660:0.012508:0.006985:0.013143:0.011738:0.006985:0.011699:0.011738:0.013181:0.012508:0.005792:0.003848:0.010314:0.003848:0.011738:0.012950:0.006975:0.013123:0.005713:0.012508:0.013181:0.003848:0.007466:0.013123:0.012604:0.007466:0.003848:0.011738:0.012950:0.005330
condition,  such as a congenital genetic :@0.084242:0.871386:0.480489:0.871386:0.480489:0.855630:0.084242:0.855630:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.003875:0.007466:0.011699:0.012450:0.011738:0.009217:0.013143:0.007466:0.009217:0.013143:0.009217:0.012450:0.012604:0.011738:0.012950:0.012508:0.011738:0.003848:0.006523:0.013143:0.003848:0.009217:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005330
disorder (e.g., Fanconi anaemia, Down’s :@0.084242:0.887591:0.480484:0.887591:0.480484:0.871835:0.084242:0.871835:0.013181:0.003848:0.007466:0.012604:0.005678:0.013181:0.012508:0.005792:0.008370:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.008370:0.009333:0.013143:0.011738:0.012450:0.012604:0.011738:0.003848:0.008370:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.008370:0.014316:0.012604:0.015990:0.011738:0.006754:0.007466:0.005330
syndrome, Bloom’s syndrome, and so on) :@0.084242:0.903797:0.480499:0.903797:0.480499:0.888041:0.084242:0.888041:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005330:0.007025:0.011045:0.003848:0.012604:0.012604:0.018049:0.006754:0.007466:0.007043:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005330:0.007025:0.013143:0.011738:0.013181:0.007043:0.007466:0.012604:0.007033:0.012604:0.011738:0.007100:0.005330
or another  predisposing haematologi-:@0.084242:0.920003:0.475157:0.920003:0.475157:0.904247:0.084242:0.904247:0.012604:0.005792:0.017857:0.013143:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330:0.012513:0.013123:0.005715:0.012508:0.013181:0.003848:0.007466:0.013123:0.012604:0.007466:0.003848:0.011738:0.012950:0.017857:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.006388
cal disorder (e.g.,  paroxysmal nocturnal :@0.084242:0.936209:0.480472:0.936209:0.480472:0.920453:0.084242:0.920453:0.012450:0.013143:0.003848:0.010526:0.013181:0.003848:0.007466:0.012604:0.005675:0.013181:0.012508:0.005792:0.010526:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.005330:0.005180:0.013123:0.013143:0.005719:0.012604:0.009236:0.010314:0.007466:0.018049:0.013143:0.003848:0.010526:0.011738:0.012604:0.012450:0.006523:0.011699:0.006181:0.011738:0.013143:0.003848:0.005330
haemoglobinuria (PNH), aplastic anae-:@0.523643:0.096130:0.914552:0.096130:0.914552:0.080374:0.523643:0.080374:0.011738:0.013143:0.012508:0.018049:0.012604:0.012950:0.003848:0.012604:0.013123:0.003848:0.011738:0.011699:0.005792:0.003848:0.013143:0.013835:0.007100:0.011392:0.014239:0.013143:0.007100:0.005330:0.013835:0.013143:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.013835:0.013143:0.011738:0.013143:0.012508:0.006388
mia, myeloproliferative neoplasms, and :@0.523643:0.112323:0.919882:0.112323:0.919882:0.096567:0.523643:0.096567:0.018049:0.003848:0.013143:0.005330:0.013239:0.018049:0.010314:0.012508:0.003848:0.012604:0.013123:0.005715:0.012604:0.003848:0.003848:0.006042:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.013239:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.007466:0.005330:0.013239:0.013143:0.011738:0.013181:0.005330
so on). Whether the presence of autoim-:@0.523643:0.128515:0.914577:0.128515:0.914577:0.112759:0.523643:0.112759:0.007466:0.012604:0.007524:0.012604:0.011738:0.007100:0.005330:0.007524:0.018473:0.011738:0.012508:0.006523:0.011738:0.012494:0.005792:0.007524:0.006523:0.011738:0.012508:0.007524:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.007524:0.012604:0.006042:0.007524:0.013143:0.011699:0.006523:0.012604:0.003848:0.018049:0.006388
mune disorders seen in association with :@0.523643:0.144708:0.919865:0.144708:0.919865:0.128952:0.523643:0.128952:0.018049:0.011699:0.011738:0.012508:0.010487:0.013181:0.003848:0.007466:0.012604:0.005678:0.013181:0.012508:0.005792:0.007466:0.010487:0.007466:0.012508:0.012508:0.011738:0.010487:0.003848:0.011738:0.010487:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.010487:0.015990:0.003848:0.006523:0.011738:0.005330
MDS, is causal or not is less clear. Depend-:@0.523643:0.160900:0.914562:0.160900:0.914562:0.145144:0.523643:0.145144:0.017684:0.014316:0.009583:0.005330:0.005453:0.003848:0.007466:0.005465:0.012450:0.013143:0.011699:0.007466:0.013143:0.003848:0.005465:0.012604:0.005792:0.005449:0.011738:0.012604:0.006523:0.005444:0.003848:0.007466:0.005465:0.003848:0.012508:0.007466:0.007466:0.005465:0.012450:0.003848:0.012508:0.013143:0.004381:0.005330:0.005451:0.014316:0.012508:0.013123:0.012508:0.011738:0.013181:0.006388
ing on the nature of the stem-cell muta-:@0.523643:0.177093:0.914565:0.177093:0.914565:0.161337:0.523643:0.161337:0.003848:0.011738:0.012950:0.008165:0.012604:0.011738:0.008159:0.006523:0.011738:0.012508:0.008161:0.011738:0.013143:0.006523:0.011699:0.005711:0.012508:0.008165:0.012604:0.006042:0.008161:0.006523:0.011738:0.012508:0.008161:0.007466:0.006523:0.012508:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.008178:0.018049:0.011699:0.006523:0.013143:0.006388
tion,  different  cell lines may be  variably :@0.523643:0.193285:0.919886:0.193285:0.919886:0.177529:0.523643:0.177529:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.004597:0.013181:0.003848:0.006104:0.006042:0.012508:0.005709:0.012508:0.011738:0.006523:0.005330:0.004599:0.012450:0.012508:0.003848:0.003848:0.009948:0.003848:0.003848:0.011738:0.012508:0.007466:0.009948:0.018049:0.013143:0.010314:0.009948:0.013123:0.012508:0.005330:0.004607:0.010660:0.013143:0.005792:0.003848:0.013143:0.013123:0.003848:0.010314:0.005330
affected, with a variable  risk of progres-:@0.523643:0.209478:0.914538:0.209478:0.914538:0.193722:0.523643:0.193722:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.008986:0.015990:0.003848:0.006523:0.011738:0.008986:0.013143:0.008986:0.010660:0.013143:0.005792:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330:0.003671:0.005792:0.003848:0.007466:0.009660:0.008986:0.012604:0.006042:0.008986:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.006388
sion to AML. Other factors, such as comor-:@0.523643:0.225670:0.914552:0.225670:0.914552:0.209914:0.523643:0.209914:0.007466:0.003848:0.012604:0.011738:0.005080:0.006523:0.012604:0.005070:0.014239:0.017684:0.008890:0.005330:0.005080:0.016722:0.006523:0.011738:0.012508:0.005792:0.005068:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330:0.005068:0.007466:0.011699:0.012450:0.011738:0.005080:0.013143:0.007466:0.005080:0.012450:0.012604:0.018049:0.012604:0.005767:0.006388
bidities,  transfusion needs, the degree of :@0.523643:0.241863:0.919892:0.241863:0.919892:0.226107:0.523643:0.226107:0.013123:0.003848:0.013181:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.005330:0.003017:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.008332:0.011738:0.012508:0.012508:0.013181:0.007466:0.005330:0.008332:0.006523:0.011738:0.012508:0.008332:0.013181:0.012508:0.012950:0.005709:0.012508:0.012508:0.008332:0.012604:0.006042:0.005330
anaemia, transfusion-related iron over-:@0.523643:0.258055:0.914573:0.258055:0.914573:0.242299:0.523643:0.242299:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.015432:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.006388:0.005715:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.015432:0.003848:0.005717:0.012604:0.011738:0.015432:0.012604:0.010660:0.012508:0.005792:0.006388
load and its complications, may impact :@0.523643:0.274248:0.919882:0.274248:0.919882:0.258492:0.523643:0.258492:0.003848:0.012604:0.013143:0.013181:0.009313:0.013143:0.011738:0.013181:0.009313:0.003848:0.006523:0.007466:0.009313:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.009313:0.018049:0.013143:0.010314:0.009313:0.003848:0.018049:0.013123:0.013143:0.012450:0.006523:0.005330
negatively on disease progression, bone-:@0.523643:0.290440:0.914567:0.290440:0.914567:0.274684:0.523643:0.274684:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.003848:0.010314:0.007755:0.012604:0.011738:0.007739:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007755:0.013123:0.005717:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.007755:0.013123:0.012604:0.011738:0.012508:0.006388
marrow function and overall survival.:@0.523643:0.306633:0.865807:0.306633:0.865807:0.290877:0.523643:0.290877:0.018049:0.013143:0.005792:0.005711:0.012604:0.015990:0.005330:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.005330:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330
TREATMENT OF MDS:@0.523636:0.339651:0.741417:0.339651:0.741417:0.320055:0.523636:0.320055:0.009878:0.013641:0.012230:0.017404:0.009878:0.021167:0.012230:0.017404:0.009878:0.006585:0.019756:0.011289:0.006585:0.021167:0.016463:0.012230
Treatment of MDS is based on the subtype of :@0.523636:0.358134:0.919931:0.358134:0.919931:0.342378:0.523636:0.342378:0.007043:0.005136:0.011930:0.012565:0.005946:0.017472:0.011930:0.011161:0.005946:0.004599:0.012027:0.005465:0.004599:0.017106:0.013739:0.009005:0.004599:0.003271:0.006889:0.004599:0.012546:0.012565:0.006889:0.011930:0.012604:0.004599:0.012027:0.011161:0.004599:0.005946:0.011161:0.011930:0.004599:0.006889:0.011122:0.012546:0.005946:0.009737:0.012546:0.011930:0.004599:0.012027:0.006042:0.005330
MDS, patient-related factors (e.g., age, per-:@0.523636:0.374181:0.914543:0.374181:0.914543:0.358425:0.523636:0.358425:0.017106:0.013739:0.009005:0.004753:0.006196:0.012546:0.012565:0.005946:0.003271:0.011930:0.011161:0.005946:0.005811:0.005136:0.011930:0.003271:0.012565:0.005946:0.011930:0.012604:0.006196:0.005465:0.012565:0.011873:0.005946:0.012027:0.005215:0.006889:0.006196:0.006523:0.011930:0.004753:0.012373:0.004753:0.004753:0.006196:0.012565:0.012373:0.011930:0.004753:0.006196:0.012546:0.011930:0.005215:0.006388
formance status, patient  preferences and :@0.523636:0.390228:0.919914:0.390228:0.919914:0.374472:0.523636:0.374472:0.005465:0.012027:0.005748:0.017472:0.012565:0.011161:0.011873:0.011930:0.010603:0.006889:0.005946:0.012565:0.005946:0.011122:0.006889:0.004753:0.010603:0.012546:0.012565:0.005946:0.003271:0.011930:0.011161:0.005946:0.005330:0.005263:0.012546:0.005134:0.011930:0.005465:0.011930:0.005136:0.011930:0.011161:0.011873:0.011930:0.006889:0.010603:0.012565:0.011161:0.013183:0.005330
comorbidities), and predictive factors for :@0.523636:0.406275:0.919868:0.406275:0.919868:0.390519:0.523636:0.390519:0.011873:0.012027:0.017472:0.012027:0.005215:0.012546:0.003271:0.012604:0.003271:0.005946:0.003271:0.011930:0.006889:0.006523:0.004753:0.013277:0.012565:0.011161:0.012604:0.013277:0.012546:0.005136:0.011930:0.012604:0.003271:0.011873:0.005946:0.003271:0.010083:0.011930:0.013277:0.005465:0.012565:0.011873:0.005946:0.012027:0.005215:0.006889:0.013277:0.005465:0.012027:0.005786:0.005330
treatment outcome (e.g., classification of an :@0.523636:0.422322:0.919904:0.422322:0.919904:0.406566:0.523636:0.406566:0.005946:0.005134:0.011930:0.012565:0.005946:0.017472:0.011930:0.011161:0.005946:0.004649:0.012027:0.011122:0.005946:0.011873:0.012027:0.017472:0.011930:0.004649:0.006523:0.011930:0.004753:0.012373:0.004753:0.004753:0.004649:0.011873:0.003271:0.012565:0.006889:0.006889:0.003271:0.004397:0.004397:0.011873:0.012565:0.005946:0.003271:0.012027:0.011161:0.004649:0.012027:0.005465:0.004647:0.012565:0.011734:0.005330
individual patient as :@0.523636:0.438369:0.704514:0.438369:0.704514:0.422613:0.523636:0.422613:0.003271:0.011161:0.012604:0.003271:0.010083:0.003271:0.012604:0.011122:0.012565:0.003271:0.004753:0.012546:0.012565:0.005946:0.003271:0.011930:0.011161:0.005946:0.004753:0.012565:0.006889:0.005330
lower:@0.703937:0.438369:0.752370:0.438369:0.752370:0.422613:0.703937:0.422613:0.003271:0.012027:0.015413:0.011930:0.005792
 or :@0.751793:0.438369:0.779117:0.438369:0.779117:0.422613:0.751793:0.422613:0.004753:0.012027:0.005215:0.005330
higher:@0.778540:0.438369:0.834228:0.438369:0.834228:0.422613:0.778540:0.422613:0.011161:0.003271:0.012373:0.011161:0.011930:0.005792
 risk).:@0.833650:0.438369:0.874714:0.438369:0.874714:0.422613:0.833650:0.422613:0.004753:0.005215:0.003271:0.006889:0.009082:0.006523:0.005330
Roughly one-third of patients have a :@0.541820:0.454416:0.919864:0.454416:0.919864:0.438660:0.541820:0.438660:0.011680:0.012604:0.011699:0.012950:0.011738:0.003848:0.010314:0.011796:0.012604:0.011738:0.012508:0.006388:0.006523:0.011724:0.003848:0.005678:0.013181:0.011796:0.012604:0.006042:0.011796:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.011796:0.011738:0.013143:0.010660:0.012508:0.011796:0.013143:0.005330
stable, non-progressive  course; one-third :@0.523636:0.470463:0.919883:0.470463:0.919883:0.454707:0.523636:0.454707:0.007466:0.006523:0.013143:0.013123:0.003848:0.012508:0.005330:0.009968:0.011738:0.012604:0.011738:0.006388:0.013123:0.005707:0.012604:0.012950:0.005711:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.005330:0.004649:0.012450:0.012604:0.011699:0.005792:0.007466:0.012508:0.005330:0.009968:0.012604:0.011738:0.012508:0.006388:0.006523:0.011738:0.003848:0.005665:0.013181:0.005330
will die from  cytopenic  complications :@0.523636:0.486510:0.919870:0.486510:0.919870:0.470754:0.523636:0.470754:0.015990:0.003848:0.003848:0.003848:0.016048:0.013181:0.003848:0.012508:0.016048:0.006042:0.005713:0.012604:0.018049:0.005330:0.010706:0.012450:0.010314:0.006523:0.012604:0.013123:0.012508:0.011738:0.003848:0.012450:0.005330:0.010706:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
(e.g., bleeding or infections) and one-third :@0.523636:0.502557:0.919864:0.502557:0.919864:0.486801:0.523636:0.486801:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.004426:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.004426:0.012604:0.005792:0.004426:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.007100:0.004426:0.013143:0.011738:0.013181:0.004426:0.012604:0.011738:0.012508:0.006388:0.006523:0.011738:0.003848:0.005665:0.013181:0.005330
will die from AML.  A range of prognostic :@0.523636:0.518604:0.919900:0.518557:0.919900:0.502801:0.523636:0.502848:0.015990:0.003848:0.003848:0.003848:0.006419:0.013181:0.003848:0.012508:0.006408:0.006042:0.005713:0.012604:0.018049:0.006408:0.014239:0.017684:0.008890:0.005330:0.012417:0.006408:0.014239:0.006408:0.005792:0.013143:0.011738:0.012950:0.012508:0.006396:0.012604:0.006042:0.006408:0.013123:0.005717:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:-0.191372
11:@0.688478:0.512938:0.700908:0.512938:0.700908:0.503752:0.688478:0.503752:0.006215:0.006215
scoring systems has been described over :@0.523632:0.534604:0.919883:0.534604:0.919883:0.518848:0.523632:0.518848:0.007466:0.012450:0.012604:0.005792:0.003848:0.011738:0.012950:0.007277:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.007466:0.007293:0.011738:0.013143:0.007466:0.007293:0.013123:0.012508:0.012508:0.011738:0.007281:0.013181:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.012508:0.013181:0.007293:0.012604:0.010660:0.012508:0.005792:0.005330
the  years,  with  continuous  refinement  as :@0.523632:0.550651:0.919866:0.550651:0.919866:0.534895:0.523632:0.534895:0.006523:0.011738:0.012508:0.005330:0.003441:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.005330:0.003444:0.015990:0.003848:0.006523:0.011738:0.005330:0.003446:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.011699:0.012604:0.011699:0.007466:0.005330:0.003435:0.005713:0.012508:0.004686:0.004686:0.011738:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.003433:0.013143:0.007466:0.005330
our  understanding  of  the  prognostic  im-:@0.523632:0.566697:0.914536:0.566697:0.914536:0.550942:0.523632:0.550942:0.012604:0.011699:0.005792:0.005330:0.004385:0.011699:0.011738:0.013181:0.012508:0.005792:0.007466:0.006523:0.013143:0.011738:0.013171:0.003848:0.011738:0.012950:0.005330:0.004393:0.012604:0.006042:0.005330:0.004389:0.006523:0.011738:0.012508:0.005330:0.004387:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005330:0.004385:0.003848:0.018049:0.006388
pact of certain clinical and pathological :@0.523632:0.582744:0.919872:0.582744:0.919872:0.566989:0.523632:0.566989:0.013123:0.013143:0.012450:0.006523:0.007601:0.012604:0.006042:0.007587:0.012450:0.012508:0.005792:0.006523:0.013143:0.003848:0.011738:0.007585:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.007601:0.013143:0.011738:0.013181:0.007591:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330
features has grown. The most widely used :@0.523632:0.598791:0.919885:0.598791:0.919885:0.583036:0.523632:0.583036:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.006177:0.011738:0.013143:0.007466:0.006177:0.012950:0.005711:0.012604:0.015990:0.011738:0.005330:0.006161:0.008197:0.011738:0.012508:0.006159:0.018049:0.012604:0.007466:0.006523:0.006177:0.015990:0.003848:0.013181:0.012508:0.003848:0.010314:0.006177:0.011699:0.007466:0.012508:0.013181:0.005330
prognostic  scoring  system used at  pre-:@0.523632:0.614838:0.914555:0.614838:0.914555:0.599082:0.523632:0.599082:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005330:0.006754:0.007466:0.012450:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330:0.006758:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.012103:0.011699:0.007466:0.012508:0.013181:0.012103:0.013143:0.006523:0.005330:0.006764:0.013123:0.005715:0.012508:0.006388
sent is the Revised International Prognos-:@0.523632:0.630885:0.914541:0.630885:0.914541:0.615129:0.523632:0.615129:0.007466:0.012508:0.011738:0.006523:0.008005:0.003848:0.007466:0.008005:0.006523:0.011738:0.012508:0.008005:0.011680:0.012508:0.010660:0.003848:0.007466:0.012508:0.013181:0.008005:0.004349:0.011738:0.006523:0.012508:0.006186:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.008005:0.011392:0.005707:0.012604:0.012950:0.011738:0.012604:0.007445:0.006388
tic Scoring System (IPSS-R) (see Table 1).  :@0.523632:0.646932:0.919875:0.646895:0.919875:0.631139:0.523632:0.631176:0.006523:0.003848:0.012450:0.007100:0.009583:0.012450:0.012604:0.005792:0.003848:0.011738:0.012950:0.007085:0.009583:0.010314:0.007466:0.006523:0.012508:0.018049:0.007100:0.007100:0.004349:0.011392:0.009583:0.009583:0.006388:0.011680:0.007100:0.007100:0.007100:0.007466:0.012508:0.012508:0.007100:0.007199:0.013143:0.013123:0.003848:0.012508:0.007100:0.010660:0.007100:0.005330:0.012428:-0.378020
12:@0.902110:0.641276:0.914540:0.641276:0.914540:0.632090:0.902110:0.632090:0.006215:0.006215
Very-low-  and low-risk patients are  usu-:@0.523635:0.662942:0.914562:0.662942:0.914562:0.647186:0.523635:0.647186:0.011567:0.012508:0.005792:0.010314:0.006388:0.003848:0.012604:0.015990:0.006388:0.005330:0.006338:0.013143:0.011738:0.013181:0.011680:0.003848:0.012604:0.015990:0.006388:0.005792:0.003848:0.007466:0.009660:0.011680:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.011680:0.013143:0.005715:0.012508:0.005330:0.006338:0.011699:0.007466:0.011699:0.006388
ally  classified  and  treated  as:@0.523635:0.678989:0.817880:0.678989:0.817880:0.663233:0.523635:0.663233:0.013143:0.003848:0.003848:0.010314:0.005330:0.007439:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.007433:0.013143:0.011738:0.013181:0.005330:0.007429:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330:0.007424:0.013143:0.007466
 lower:@0.817880:0.678989:0.881380:0.678989:0.881380:0.663233:0.817880:0.663233:0.012758:0.003848:0.012604:0.015990:0.012508:0.005792
-risk :@0.881380:0.678989:0.919865:0.678989:0.919865:0.663233:0.881380:0.663233:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330
patients, while high- and very-high-risk :@0.523635:0.695036:0.919875:0.695036:0.919875:0.679280:0.523635:0.679280:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.014740:0.015990:0.011738:0.003848:0.003848:0.012508:0.014740:0.011738:0.003848:0.012950:0.011738:0.006388:0.014740:0.013143:0.011738:0.013181:0.014740:0.010660:0.012508:0.005792:0.010314:0.006388:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330
patients are considered :@0.523635:0.711083:0.765260:0.711083:0.765260:0.695327:0.523635:0.695327:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.012431:0.013143:0.005715:0.012508:0.012431:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.012508:0.005713:0.012508:0.013181:0.005330
higher:@0.772360:0.711083:0.830934:0.711083:0.830934:0.695327:0.772360:0.695327:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792
-risk and :@0.830898:0.711083:0.919875:0.711083:0.919875:0.695327:0.830898:0.695327:0.006388:0.005792:0.003848:0.007466:0.009660:0.012431:0.013143:0.011738:0.013181:0.005330
treated as  such. Patients who fall  in the :@0.523635:0.727130:0.919877:0.727130:0.919877:0.711374:0.523635:0.711374:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.009256:0.013143:0.007466:0.005330:0.003937:0.007466:0.011699:0.012450:0.011738:0.005330:0.009256:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009256:0.015990:0.011738:0.012604:0.009256:0.006042:0.013143:0.003848:0.003848:0.005330:0.003939:0.003848:0.011738:0.009256:0.006523:0.011738:0.012508:0.005330
intermediate category can be treated as :@0.523635:0.743177:0.919888:0.743177:0.919888:0.727421:0.523635:0.727421:0.003848:0.011738:0.006523:0.012508:0.006319:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.006061:0.012450:0.013143:0.006523:0.012508:0.012950:0.012604:0.005792:0.010314:0.006044:0.012450:0.013143:0.011738:0.006061:0.013123:0.012508:0.006061:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.006052:0.013143:0.007466:0.005330
either:@0.523635:0.759224:0.576552:0.759224:0.576552:0.743468:0.523635:0.743468:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792
 lower:@0.576552:0.759224:0.632432:0.759224:0.632432:0.743468:0.576552:0.743468:0.005138:0.003848:0.012604:0.015990:0.012508:0.005792
 or :@0.632432:0.759224:0.661295:0.759224:0.661295:0.743468:0.632432:0.743468:0.005138:0.012604:0.005792:0.005330
higher:@0.661103:0.759224:0.719677:0.759224:0.719677:0.743468:0.661103:0.743468:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792
 risk, depending on a :@0.719657:0.759224:0.919894:0.759224:0.919894:0.743468:0.719657:0.743468:0.005138:0.005792:0.003848:0.007466:0.009660:0.005330:0.005138:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.005138:0.012604:0.011738:0.005138:0.013143:0.005330
range of individual factors. Survival varies :@0.523654:0.775271:0.919884:0.775271:0.919884:0.759515:0.523654:0.759515:0.005792:0.013143:0.011738:0.012950:0.012508:0.007014:0.012604:0.006042:0.007023:0.003848:0.011738:0.013181:0.003848:0.010660:0.003848:0.013196:0.011699:0.013143:0.003848:0.007023:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330:0.007014:0.009583:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.007037:0.010660:0.013143:0.005792:0.003848:0.012508:0.007466:0.005330
from weeks to several years, depending :@0.523654:0.791318:0.919890:0.791318:0.919890:0.775562:0.523654:0.775562:0.006042:0.005711:0.012604:0.018049:0.009198:0.015990:0.012508:0.012508:0.009660:0.007466:0.009198:0.006523:0.012604:0.009198:0.007466:0.012508:0.010660:0.012508:0.005792:0.013143:0.003848:0.009198:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.009198:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330
on the risk group.:@0.523654:0.807365:0.682918:0.807365:0.682918:0.791609:0.523654:0.791609:0.012604:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330:0.012950:0.005690:0.012604:0.011699:0.013123:0.005330
The  goal  of  treatment  in patients with :@0.541838:0.823412:0.919911:0.823412:0.919911:0.807656:0.541838:0.807656:0.008197:0.011738:0.012508:0.005330:0.004216:0.012950:0.012604:0.013143:0.003848:0.005330:0.004224:0.012604:0.006042:0.005330:0.004222:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004218:0.003848:0.011738:0.009563:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009563:0.015990:0.003848:0.006523:0.011738:0.005330
lower:@0.523654:0.839458:0.574396:0.839458:0.574396:0.823703:0.523654:0.823703:0.003848:0.012604:0.015990:0.012508:0.005792
-risk  MDS  is to  improve  symptoms :@0.574396:0.839458:0.919898:0.839458:0.919898:0.823703:0.574396:0.823703:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.007649:0.017684:0.014316:0.009583:0.005330:0.007645:0.003848:0.007466:0.012989:0.006523:0.012604:0.005330:0.007639:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.005330:0.007643:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330
related to  anaemia and other  cytopae-:@0.523654:0.855505:0.914569:0.855505:0.914569:0.839750:0.523654:0.839750:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.008909:0.006523:0.012604:0.005330:0.003568:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.008909:0.013143:0.011738:0.013181:0.008909:0.012604:0.006523:0.011728:0.012508:0.005792:0.005330:0.003569:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.006388
nias, improve quality of life and improve :@0.523654:0.871552:0.919898:0.871552:0.919898:0.855797:0.523654:0.855797:0.011738:0.003848:0.013143:0.007466:0.005330:0.008486:0.003848:0.018049:0.013123:0.005715:0.012604:0.010660:0.012508:0.008486:0.013123:0.011699:0.013143:0.003848:0.003848:0.006523:0.010314:0.008486:0.012604:0.006042:0.008486:0.003848:0.003848:0.006042:0.012508:0.008486:0.013143:0.011738:0.013181:0.008486:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.005330
haematology, while the goal of therapy in :@0.523654:0.887745:0.919903:0.887745:0.919903:0.871989:0.523654:0.871989:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.004916:0.015990:0.011738:0.003848:0.003848:0.012508:0.004926:0.006523:0.011738:0.012508:0.004926:0.012950:0.012604:0.013143:0.003848:0.004926:0.012604:0.006042:0.004926:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004926:0.003848:0.011738:0.005330
higher:@0.523654:0.903937:0.582228:0.903937:0.582228:0.888182:0.523654:0.888182:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792
-risk disease is to either modify the :@0.582209:0.903937:0.919884:0.903937:0.919884:0.888182:0.582209:0.888182:0.006388:0.005792:0.003848:0.007466:0.009660:0.008486:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.008486:0.003848:0.007466:0.008486:0.006523:0.012604:0.008486:0.012508:0.003848:0.006523:0.011738:0.012508:0.005782:0.008486:0.018049:0.012604:0.013181:0.003848:0.006042:0.010314:0.008486:0.006523:0.011738:0.012508:0.005330
natural history of the disease by delaying :@0.523654:0.920130:0.919902:0.920130:0.919902:0.904374:0.523654:0.904374:0.011738:0.013143:0.006523:0.011699:0.005792:0.013143:0.003848:0.007043:0.011738:0.003848:0.007466:0.006523:0.012604:0.005792:0.010314:0.007043:0.012604:0.006042:0.007043:0.006523:0.011738:0.012508:0.007031:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007043:0.013123:0.010314:0.007043:0.013181:0.012508:0.003848:0.013143:0.010314:0.003848:0.011738:0.012950:0.005330
disease progression and improving survival :@0.523654:0.936322:0.919869:0.936322:0.919869:0.920567:0.523654:0.920567:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.004330:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.004330:0.013143:0.011738:0.013181:0.004330:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.003848:0.011738:0.012950:0.004330:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330